RFA - Einsteinium (EMC2) Award

 EMC2 Awards/2018 - The Einsteinium Foundation Awards page is live! Check it out at:  https://www.emc2.foundation/einsteinium-awards/   The Einsteinium Foundation invites projects for consideration for our annual award with the winner to be announced in mid-September 2018. We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.  Contact  projects@emc2.foundation  for more information.

EMC2 Awards/2018 - The Einsteinium Foundation Awards page is live! Check it out at: https://www.emc2.foundation/einsteinium-awards/

The Einsteinium Foundation invites projects for consideration for our annual award with the winner to be announced in mid-September 2018. We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.

Contact projects@emc2.foundation for more information.

Call for Applications - Einsteinium(EMC2) Awards

 EMC2 Awards/2018 - in California. Submit your work now. The Einsteinium Foundation invites projects for consideration for our annual award with the winner to be announced in mid-September 2018. Interested? Contact  projects@emc2.foundation  for more information.   We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.

EMC2 Awards/2018 - in California. Submit your work now. The Einsteinium Foundation invites projects for consideration for our annual award with the winner to be announced in mid-September 2018. Interested? Contact projects@emc2.foundation for more information.

 We invite applications cutting across broad interests in science. Be ready to discuss latest findings and current research directions.

Global Cell Med (GCM) is on a mission to treat diabetes

Global Cell Med (GCM) is on a mission to treat diabetes

Global Cell Med (GCM) is not a household name, but someday that could change. The organization, based out of the Bahamas, under the direction of Dr. Alejandro Mesples has been working on a procedure to treat Diabetes Type One, a global epidemic currently affecting more than 30 million adults and children in the US alone.